Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Heron Therapeutics Inc (HRTX) Price & Performance

BioNTech SE - ADRTrade
Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Heron Therapeutics Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: BioNTech SE - ADR is far larger — about 379.2× Heron Therapeutics Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

BNTXHRTX
Market Cap
$23.31B$61.47M
Sector
HealthHealth
52-Week High
$119.34$1.49
52-Week Low
$83.89$0.32
Enterprise Value
$6.60B$168.21M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX